SCHEMBL869481

SCHEMBL869481

N#Cc1c(Cl)cncc1-c1ccc2c(c1)CCN2C(=O)Cc1cccc(C(F)(F)F)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 15/20 0.56
▸ EIF2AK3 Q9NZJ5 4/20 0.56
▸ EIF2AK2 P19525 2/20 0.56
▸ EIF2AK1 Q9BQI3 2/20 0.56
▸ NTRK1 P04629 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ LCK P06239 1/20 0.56
▸ YES1 P07947 1/20 0.56
▸ RET P07949 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ CYP2C8 P10632 1/20 0.56
▸ CYP2D6 P10635 1/20 0.56
▸ KIT P10721 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ AXL P30530 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ NEK4 P51957 1/20 0.56
▸ MAP3K9 P80192 1/20 0.56
▸ MAP3K10 Q02779 1/20 0.56
▸ MERTK Q12866 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL869334 0.87 EIF2AK3 (0.55) RIPK1EIF2AK3EIF2AK2EIF2AK1CYP11B1
SCHEMBL16386454 0.80 RIPK1 (0.59) RIPK1EIF2AK3EIF2AK2EIF2AK1NTRK1
SCHEMBL869180 0.79 RIPK1 (0.66) RIPK1EIF2AK3EIF2AK2EIF2AK1NTRK1
SCHEMBL30774488 0.79 RIPK1 (0.48) RIPK1EIF2AK3EIF2AK2EIF2AK1NTRK1
SCHEMBL868831 0.78 RIPK1 (0.65) RIPK1EIF2AK3EIF2AK2EIF2AK1NTRK1
SCHEMBL13860439 0.76 EIF2AK3 (0.55) RIPK1EIF2AK3EIF2AK2EIF2AK1NTRK1
SCHEMBL14655478 0.75 RIPK1 (0.56) RIPK1EIF2AK3EIF2AK2EIF2AK1NTRK1
SCHEMBL869066 0.74 RIPK1 (0.55) RIPK1EIF2AK3EIF2AK2EIF2AK1NTRK1
SCHEMBL16660364 0.74 RIPK1 (0.66) RIPK1EIF2AK3EIF2AK2EIF2AK1NTRK1
SCHEMBL869349 0.74 EIF2AK3 (0.79) RIPK1EIF2AK3EIF2AK2EIF2AK1NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2549868-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2015-01-07 — — EP disclosed
US-8598156-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2013-12-03 — — US disclosed
EP-2549868-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2013-01-30 — — EP disclosed
US-20130018038-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2013-01-17 — — US disclosed
US-20120077828-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2012-03-29 — — US disclosed
WO-2011119663-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-09-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018038-A1 CHEMICAL COMPOUNDS BRCA1, IRS1, IGF1R RIPK1 218/4885EIF2AK3 16/4885EIF2AK2 174/4885
US-20120077828-A1 CHEMICAL COMPOUNDS BRCA1, IRS1, IGF1R RIPK1 218/4885EIF2AK3 16/4885EIF2AK2 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback